AVBP - Company ID 0001868279
As of 2026-11-06, ArriVent BioPharma, Inc. (AVBP) has a market capitalization of $623.00 M, making it the #2626 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $623.00 M |
| 2026-11-05 | $603.03 M |
| 2026-11-04 | $646.92 M |
| 2026-11-03 | $649.38 M |
| 2026-11-02 | $658.26 M |
| 2026-11-01 | $692.57 M |
| 2026-10-31 | $692.57 M |
| 2026-10-30 | $676.73 M |
| 2026-10-29 | $742.87 M |
| 2026-10-28 | $724.71 M |
| 2026-10-27 | $714.93 M |
| 2026-10-26 | $715.39 M |
As of 2026-11-06, ArriVent BioPharma, Inc. (AVBP) has a market capitalization of $623.00 M, making it the #2626 most valuable US-listed company.
ArriVent BioPharma, Inc. is the #2626 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $978.07 M |
| 2026-10-24 | $978.07 M |
| 2026-10-23 | $978.07 M |
| 2026-10-22 | $884.92 M |
| 2026-10-21 | $890.51 M |
| 2026-10-20 | $877.94 M |
| 2026-10-19 | $835.55 M |
| 2026-10-18 | $775.94 M |
| 2026-10-17 | $775.94 M |
| 2026-10-16 | $775.94 M |
| 2026-10-15 | $769.18 M |
| 2026-10-14 | $754.51 M |
| 2026-10-13 | $749.39 M |
| 2026-10-12 | $766.62 M |
| 2026-10-11 | $779.20 M |
| 2026-10-10 | $779.20 M |
| 2026-10-09 | $779.20 M |
| 2026-10-08 | $778.27 M |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.